Logo

American Heart Association

  56
  0


Final ID:

Mortality or bust: what makes for a meaningful VT trial outcome?

  • Stevenson, William  ( Vanderbilt University Medical Ctr , Nashville , Tennessee , United States )
  • Gerstenfeld, Edward  ( UCSF , SanFrancisco , California , United States )
  • Author Disclosures:
    William Stevenson: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):abbott speaking honoria:Active (exists now) ; Researcher:Adagio:Active (exists now) ; Other (please indicate in the box next to the company name):Mediasphere- speaking honoria:Active (exists now) ; Other (please indicate in the box next to the company name):Biotronik speaking honoria:Past (completed) ; Other (please indicate in the box next to the company name):Boston Scientific - speaking honoria:Active (exists now) ; Other (please indicate in the box next to the company name):JOhnson and Johnson - speaking honoria:Active (exists now) | Edward GERSTENFELD: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott:Past (completed) ; Consultant:Adagio Medical:Past (completed) ; Consultant:Medtronic:Active (exists now) ; Consultant:Biosense-Webster:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Abbott:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Defining Success in EP Clinical Trials

Friday, 11/07/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

You have to be authorized to contact abstract author. Please, Login
Not Available